New research by Boston Children’s Hospital on ricolinostat repurposing to curb neutrophil extracellular traps (NETs) and to fight severe inflammation in Covid-19
As we’ve seen during the COVID-19 pandemic, serious infections sometimes trigger an excessive inflammatory reaction that does as much harm — or more — than the infection itself. New research at Boston Children’s Hospital and Brigham and Women’s Hospital suggests a potential way to block this hyperinflammation response by repurposing or modifying an existing drug.